Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage
Stroke 52:1390-1397, Micieli, A.,et al, 2021
Oral Anticoagulants for Prevention of Stroke in Atrial Fibrillation: Systematic Review, Network Meta-Analysis, and Cost Effectiveness Analysis
BMJ 359:J5058, Lopez-Lopez, J.A.,et al, 2017
Optimal Screening Strategy for Familial Intracranial Aneurysms: A Cost-Effectiveness Analysis
Neurol 74:1671-1679, Bor,A.S.E., et al, 2010
Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage
Stroke 37:2751-2758, Earnshaw,S.R.,et al, 2006
Risk of Hemorrhagic Stroke With Aspirin Use
Stroke 36:1801-1807, Gorelick,P.B. &Weisman,S.M., 2005
Inpatient Costs, Length of Stay, and Mortality for Cerebrovascular Events in Community Hospitals
Neurol 57:305-314, Reed,S.D.,et al, 2001
Recommendations for the Management of Patients with Unruptured Intracranial Aneurysms
Stroke 31:2742-2750, Bederson,J.B.,et al, 2000
Follow-up of Conservatively Managed Epidural Hematomas:Implications for Timing of Repeat CT
AJNR 20:107-113,115, Sullivan,T.P.,et al, 1999
Which Unruptured Cerebral Aneurysms Should be Treated? A Cost-Utility Analysis
Neurol 52:1806-1815, Johnston,S.C.,et al, 1999
MR Imaging in Pretruncal Nonaneurysmal Subarachnoid Hemorrhage,Is It Worthwhile?
Stroke 29:2514-2516, Wijdicks,E.F.M.,et al, 1998
Inpatient Costs of Specific Cerebrovascular Events at Five Academic Medical Centers
Neurol 46:854-860, 6021996., Holloway,R.G.,et al, 1996
Utilization of Acute Care Services in the Year Before and After First Stroke:A Population-Based Study
Neurol 46:861-869, 6021996., Leibson,C.L.,et al, 1996